Devin B. Lowe Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology Texas Tech University Health Sciences Center Biography Publications Institution JoVE Articles Devin B. Lowe has not added a biography. If you are Devin B. Lowe and would like to personalize this page please email our Author Liaison for assistance. Publications Monitoring Antigen-specific T Cell Responses Using Real-time PCR Methods in Molecular Biology (Clifton, N.J.). 2014 | Pubmed ID: 25149303 Dasatinib Promotes the Expansion of a Therapeutically Superior T-cell Repertoire in Response to Dendritic Cell Vaccination Against Melanoma Oncoimmunology. Jan, 2014 | Pubmed ID: 24734217 The Role of Gamma Interferon in DNA Vaccine-induced Tumor Immunity Targeting Simian Virus 40 Large Tumor Antigen Cancer Immunology, Immunotherapy : CII. Feb, 2013 | Pubmed ID: 22926061 Shock Block for Improved Immunotherapy Oncoimmunology. Nov, 2012 | Pubmed ID: 23243617 Combined Vaccine+axitinib Therapy Yields Superior Antitumor Efficacy in a Murine Melanoma Model Melanoma Research. Jun, 2012 | Pubmed ID: 22504156 Vaccines Targeting Tumor Blood Vessel Antigens Promote CD8(+) T Cell-dependent Tumor Eradication or Dormancy in HLA-A2 Transgenic Mice Journal of Immunology (Baltimore, Md. : 1950). Feb, 2012 | Pubmed ID: 22246626 Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity in Vivo Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2012 | Pubmed ID: 22215017 Chronic Inflammation and Immunologic-based Constraints in Malignant Disease Immunotherapy. Oct, 2011 | Pubmed ID: 21995576 CD4+ T Lymphocytes Are Critical Mediators of Tumor Immunity to Simian Virus 40 Large Tumor Antigen Induced by Vaccination with Plasmid DNA Journal of Virology. Jul, 2011 | Pubmed ID: 21593176 Intratumoral IL-12 Gene Therapy Results in the Crosspriming of Tc1 Cells Reactive Against Tumor-associated Stromal Antigens Molecular Therapy : the Journal of the American Society of Gene Therapy. Apr, 2011 | Pubmed ID: 21189473 Vaccines and Immunotherapeutics for the Treatment of Malignant Disease Clinical & Developmental Immunology. 2010 | Pubmed ID: 20936120 Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen Journal of Virology. Oct, 2010 | Pubmed ID: 20668083 Tumor Immunity Against a Simian Virus 40 Oncoprotein Requires CD8+ T Lymphocytes in the Effector Immune Phase Journal of Virology. Jan, 2010 | Pubmed ID: 19889780 A NOD/SCID Tumor Model for Human Ovarian Cancer That Allows Tracking of Tumor Progression Through the Biomarker Sp17 Journal of Immunological Methods. Apr, 2007 | Pubmed ID: 17336323 Fc Gamma Receptors Play a Dominant Role in Protective Tumor Immunity Against a Virus-encoded Tumor-specific Antigen in a Murine Model of Experimental Pulmonary Metastases Journal of Virology. Feb, 2007 | Pubmed ID: 17108042 DNA Vaccines: Successes and Limitations in Cancer and Infectious Disease Journal of Cellular Biochemistry. May, 2006 | Pubmed ID: 16440328 In Vitro Simian Virus 40 Large Tumor Antigen Expression Correlates with Differential Immune Responses Following DNA Immunization Virology. Feb, 2005 | Pubmed ID: 15661138 Anti-idiotype Responses Abrogate Anti-CD4-induced Tolerance to a Tumor-specific Antigen and Promote Systemic Tumor Immunity Cancer Immunology, Immunotherapy : CII. Nov, 2004 | Pubmed ID: 15156293 Påvisning av humant leukocytt antigen Biomarkører i Breast Cancer Utnytte Etikett-free Biosensor Technology Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
Påvisning av humant leukocytt antigen Biomarkører i Breast Cancer Utnytte Etikett-free Biosensor Technology Jon A. Weidanz1, Krysten L. Doll1, Soumya Mohana-Sundaram1, Timea Wichner1, Devin B. Lowe1, Susanne Gimlin2, Debra Wawro Weidanz2, Robert Magnusson2,3, Oriana E. Hawkins1 1Experimmune, A Center for Immunotherapeutic Development, Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, 2Resonant Sensors Incorporated, 3University of Texas Arlington JoVE 52159 Immunology and Infection
